SIMS KAREN (Chief Medical Officer) sold 15.4% of their position (19.35K shares) of ARBUTUS BIOPHARMA CORP on the open market
Open‑market sale worth $63.5K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/5/2025ACC: 0001447028-25-000039
Officer· Chief Medical Officer
Since Jul 2023
-19.35K
Net shares
Net seller
$63.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
19.35K disposed
Non-Derivative Transactions1
Common Shares
Direct
Shares
−19.35K
Price / share
$3.28
Trade value
$63.52K
% of position
15.4%
2/4/2025
125.54K→106.19K
Total
Net shares
−19.35K
Net value
-$63.52K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 2/4/2025 | S · Sale | −19.35K | $3.28 | $63.52K | 15.4% | 125.54K | 106.19K |
| Total | −19.35K | -$63.52K | ||||||
Derivative Transactions0
No derivative transactions reported